Chris Lau

Chris Lau

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Buy Roblox Stock to Invest in Strong Platform Growth

Roblox enjoys a wide age group of customers with broad interests in the gaming space. That will drive its profit growth and boost RBLX stock.

Coupang Stock Has 2 Major Catalysts Ahead

Coupang has Eats and Fresh, two initiatives already showing strong initial growth that should help push CPNG stock higher.

ContextLogic Needs Multiple Quarterly Wins to Make It a Buy

ContextLogic’s additional executive hires promises strong leadership ahead, but it needs earnings to go along with their new talent.

Buy Opendoor Stock If It Dips Again

OPEN stock rallied after the firm posted Q2 results that exceeded expectations, thanks to its product introductions and profitable strategy.

7 Hot Post-Pandemic Stocks Set to Soar

The markets are ignoring the strong upside ahead for post-pandemic stocks, making it a perfect time to buy hot stocks ahead of the crowd.

Why Markets Cut Short the Rally of fuboTV Stock

fuboTV reported impressive revenue, benefiting from strong subscribers growth. Investors should consider buying FUBO stock.

Chinese Regulators Are Alibaba Stock’s Only Problem

BABA stock is underperforming as regulators impose stricter restrictions on the tech sector, hurting the firm and its corporate customers.

7 Best Fintech Stocks to Buy as Digital Transactions Dominate

The price of Fintech stocks are about to rise to the upside as the post-pandemic reopening gathers steam, accelerating by Q4.

Revenue Acceleration Will Lift Senseonics

Senseonics is ready to launch Eversense CGM systems globally through its partner. Investors buying SENS stock now will get rewarded.

Avoid Clover Health Stock As Its Losses Mount

CLOV stock will continue to fade lower as operating costs rise and the digital transformation is anything but proven.